Zoom Logo

Improving Uptake of Amoxicillin and Gentamicin: Three-Part Consultation - Shared screen with speaker view
LILIAN IGUBE
22:17
I am LILIAN IGUBE FROM SOUTH SUDAN
Jane Briggs
22:21
welcome! I am Jane Briggs MNCH lead of the USAID MTaPS program
Joseph Monehin
22:24
Joseph Monehin, Senior Child Health Advisor, USAID
coumbo BOLY
22:30
BOLY du Burkina Faso
Jean Kamate
22:34
Jean Kamate, USAID Mali Mission
Sonali Daniel
22:35
Dr Sonali Daniel, Sr MNCH Expert, USAID-SAMVEG, JSIPL, from India
EBUNOLUWA Adejuyigbe
22:46
I am Prof Ebunoluwa Adejuyigbe, a neonatologist from Nigeria
Yvette Ribaira
22:56
Greetings from Madagascar. Hello everyone. I'm Yvette Ribaira, MIHR Community health lead
Ankur Sooden
22:59
Ankur Sooden, Senior Advisor Private Sector, USAID SAMVEG, JSI India
Cammie Lee (R4D)
23:00
Cammie Lee, Senior Director & Markets Shaping Practice Lead, Results for Development (R4D)
Poonam Kakani
23:29
Poonam Kakani, Program Manger PQM+ joining from Rockville, MD, USA.
JAYASHREE M
23:35
Hi Everyone ! I am Dr Jayashree from India. I am incharge of PICU and Emergency at tertiary hospital PGIMER Chandigarh India
Anaclet NGABONZIMA
23:36
NGABONZIMA Anaclet, Child Health Lead/MIHR
Nchobeni Luundu
23:41
Nchobeni Luundu-Kagula, Advisor TO 3&4 GHSC-PSM, Zambia
Patrick Gaparayi
23:51
Patrick Gaparayi, Supply Chain Manager, UNICEF, Supply division (Copenhagen). Acting as co-chair of the CHTF/commodity sub-group
Andrey Tulisov
24:32
Andrey Tulisov, UNICEF Islamabad
MURAMBE WENDO FIDELE
24:34
fidèle murambe wendo depuis Goma RDC
Fantaye Dinkashe
24:59
Fantaye Teka, Market Shaping Analyst, Results for Development (R4D)
Bali Bako
25:01
Bali Bako, FP/MNCH Logistics Advisor, GHSC-PSM Burkina Faso
Gbemisola Allwell-Brown
25:02
Gbemisola Allwell-Brown, researcher (Uppsala University, Sweden). I study antibiotic use in children across LMICs & Uganda
chris masila
25:06
Hi Everyone, Chris Masila, PractHealth Consulting, Kenya
Sita Strother
25:32
https://www.childhealthtaskforce.org/subgroups/newborn
Lauren Herzog
25:57
Si vous souhaitez écouter la reunion en français, il faut sélectionner l'option interprétation et ensuite l'option français.
Jane Briggs
35:01
Si vous souhaitez écouter la reunion en français, il faut sélectionner l'option interprétation et ensuite l'option français.
Jane Briggs
35:28
Please feel free to type any questions in the chat as the meeting proceeds
Jane Briggs
36:39
Si vous avex des questions veillez les mettre ici dans le chat, et on les addresse
Jane Briggs
38:41
Si vous souhaitez écouter la reunion en français, il faut sélectionner l'option interprétation et ensuite l'option français.
ephraim senkyire
39:36
In Ghana we store it in refrigerators after dilution up a week or more
Jane Briggs
40:25
thanks Ephraim - thats great in a hospital setting but at home it is more difficult if children are treated as outpatients
Jane Briggs
40:45
this is one reason why disp tablets are a good option for outpatient settings
Fantaye Dinkashe
41:42
Is there any recommended taste masking/ flavoring agent for Amox DT?
ephraim senkyire
41:47
so is it advisable to store in refrigerators at hospital setting
ephraim senkyire
42:47
I am referring to gentamicin
Jane Briggs
42:54
@ephraim - the syrups - yes ideally should be stored in the fridge
chris masila
44:34
Most of this products i.e. Amoxy DT and Gentamicin are locally manufactured but this varies due to GMP standards variation
Jane Briggs
44:38
Gentamicin should not be stored in the fridge
ephraim senkyire
46:32
then @ Brigg how to we change this at the hospital setting because that is the practice here in Ghana
chris masila
47:56
Countries require clear game plan on building a further business case for MNCH products manufacturing and supportive regulatory harmonization processes - WHO has launched the reliance fastr track processes not sure if some of the manufacturers have adopted this?
Jane Briggs
48:30
@Ephraim - this is a good question - it could be linked to messaging to district and health facility staff on oxytocin - which DOES need to be stored in the fridge
Jane Briggs
49:42
@Chris - exactly - this will be a good point for discussion in the interventions section- what are actionable solutions
ephraim senkyire
50:02
yes I will be glad if we can follow up with Ghana health service
chris masila
50:39
@jane some lessons from Covid-19 on regulation as we adopt the new normal in NMRA's and becoming more agile
Jane Briggs
51:25
https://www.mtapsprogram.org/our-resources/improving-access-to-maternal-newborn-and-child-health-medical-products-in-low-and-middle-income-countries-considerations-for-effective-registration-systems/
Jane Briggs
51:47
@Chris - yes - we will call on you to comment on this in a bit
chris masila
53:16
Thanks @Jane just finished an evaluation study for Kenya NMRA using a modified qualitative GBT tool thanks for sharing will read this definitely
sabbir ahmed
54:35
A sick child when visit a medical graduate, he/she already have higher antibiotic from pharmacist or traditional practisioners since regulatory system is not strong/in place or functioning. Hence in most cases a medical graduate cannot start with AmoxiDT or Inj. Genta. This is the scenario in many Asian and African countries limiting the appropriate use of Amoxi-DT/Genta.
Jane Briggs
55:01
Post marketing surveillance is the approach to check on quality of products once they are on the market
Joseph Monehin
56:10
Thanks Sabbir.The issue of appropriate use would be expatiated on at the next session on May 24.We hope you are able to attend in order to contribute to this discussion.
Jane Briggs
56:11
@Sabbir - we will ask you to expand on your point shortly
sabbir ahmed
57:10
ok. Thanks
Jane Briggs
58:28
Pour ceux qui viennent de nous joinder si vous souhaitez écouter la reunion en français, il faut sélectionner l'option interprétation et ensuite l'option français.
JAYASHREE M
01:00:11
I work in a tertiary referral hospital. many children are already on high end antibiotics prior to referral to us. It is a challenge to deescalate to ampicillin + genta which is our protocol still for community acquired pneumonia
Jane Briggs
01:01:57
Interesting point Jayashree- and very important - we will talk about appropriate use in the next session on 24 May
JAYASHREE M
01:03:09
thanks Jane. agree that appropriate use requires a full session. changing mind set is far more difficult
Jane Briggs
01:03:17
procurement unit should ensure that Amox DT is procured in blisters and not in pots of 1000 for example
Siobhan Vega
01:03:25
www.menti.comCode: 6179 7400
JAYASHREE M
01:06:51
over the counter antibiotics is a problem in India too
Jane Briggs
01:07:33
www.menti.com
Jane Briggs
01:07:44
61797400
Zelalem sahle
01:14:38
Unfulfilment of GDP and GSP requirements
Rita Anaba
01:16:45
It is very important for the authorities to ensure that all commodities are of good quality because most times these drugs are available but they don't work.
chris masila
01:17:43
cold chain integration is key beyond vaccines there is as need for further research understand the cost benefit of this at regional or facility level
Jane Briggs
01:19:27
cold chain is essential esp for products like oxytocin but is not needed for amox and gent ( with the exception of the reconstituted syrup) but temperatures should be monitored in the storage area to check it does not exceed 25 degrees
chris masila
01:24:30
The Nigeria story on CHX local manufacturing where many manufacturers came in however demand became a challenge later - supply needs to match supply is a lesson here
Cammie Lee (R4D)
01:25:18
On price and quality - they also aren't always inversely correlated. We've seen higher priced non-global quality assured amox DT procured over lower cost, global quality assured amox DT.
Siobhan Vega
01:55:22
Thanks to everyone in group 1! sorry we ran out of time
Siobhan Vega
01:55:35
please feel free to continue to provide comments in the chat
coumbo BOLY
01:56:48
pas de traduction???
Jane Briggs
01:57:04
oui choissez la langue francais
Beth Yeager
01:57:05
@Cammie: just saw your message -- agreed, complicated relationship between price and quality
Jane Briggs
01:57:11
clickez sur l'interpretation
chris masila
01:57:26
No Quality, No Program, No Global Health Outcome - key for child care products
Jane Briggs
01:57:35
yes indeed
Siobhan Vega
01:59:15
Pour ceux qui viennent de nous joinder si vous souhaitez écouter la reunion en français, il faut sélectionner l'option interprétation et ensuite l'option français.
Zelalem sahle
01:59:20
WHO listed MRA
Leah Greenspan
02:04:27
When we think About demand-I wonder how labeling amox as a child medicines and not a newborn and child medicines impacts thoughts around this the drug
Jane Briggs
02:06:06
yes Leah - it should be recognized as a medicine for newborn and child health - we talked last week about the use of 125mg DT for newborn not just using 250mg
Kristina Granger
02:10:05
Really important points Leah and Jane. Packaging and labeling are important ways to ensure correct use and to nudge use for audiences where it's underused.
Jane Briggs
02:10:50
@Kristina- yes please lets remember this point for next weeks discussion on use
Leah Greenspan
02:11:28
Thank you Jane for this
Kristina Granger
02:11:49
You can even consider packaging in relation to storage, cues on the package about temperature, etc.
Hailemariam Legesse
02:11:50
thank you very much,
JAYASHREE M
02:11:50
Thanks everyone for the interactive session
Jane Briggs
02:11:54
thanks everyone for your contributions
Zelalem sahle
02:11:58
Thank you all